CN106459895B - 制备用于3d组织培养的细胞的方法 - Google Patents

制备用于3d组织培养的细胞的方法 Download PDF

Info

Publication number
CN106459895B
CN106459895B CN201580020057.0A CN201580020057A CN106459895B CN 106459895 B CN106459895 B CN 106459895B CN 201580020057 A CN201580020057 A CN 201580020057A CN 106459895 B CN106459895 B CN 106459895B
Authority
CN
China
Prior art keywords
cells
cell
hepatocytes
tissue culture
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580020057.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN106459895A (zh
Inventor
S·梅斯纳
W·莫里茨
J·利希滕贝格
J·M·克尔姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silver Silk Buddha Co ltd
Original Assignee
Silver Silk Buddha Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Silver Silk Buddha Co ltd filed Critical Silver Silk Buddha Co ltd
Publication of CN106459895A publication Critical patent/CN106459895A/zh
Application granted granted Critical
Publication of CN106459895B publication Critical patent/CN106459895B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201580020057.0A 2014-04-15 2015-04-15 制备用于3d组织培养的细胞的方法 Active CN106459895B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1406716.9A GB201406716D0 (en) 2014-04-15 2014-04-15 Method of preparing cells for 3D tissue culture
GB1406716.9 2014-04-15
PCT/EP2015/058174 WO2015158777A1 (en) 2014-04-15 2015-04-15 Method of preparing cells for 3d tissue culture

Publications (2)

Publication Number Publication Date
CN106459895A CN106459895A (zh) 2017-02-22
CN106459895B true CN106459895B (zh) 2021-06-01

Family

ID=50844988

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580020057.0A Active CN106459895B (zh) 2014-04-15 2015-04-15 制备用于3d组织培养的细胞的方法

Country Status (10)

Country Link
US (2) US20170037364A1 (https=)
EP (1) EP3132023B1 (https=)
JP (1) JP6492106B2 (https=)
CN (1) CN106459895B (https=)
AU (1) AU2015248875B9 (https=)
CA (1) CA2945548C (https=)
DK (1) DK3132023T3 (https=)
GB (1) GB201406716D0 (https=)
SG (1) SG11201608463WA (https=)
WO (1) WO2015158777A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6758026B2 (ja) * 2015-04-17 2020-09-23 株式会社日立ハイテク 成分分析装置、薬剤成分分析装置、成分分析方法及び薬剤成分分析方法
EP3397753B1 (en) * 2015-12-30 2021-10-27 FUJIFILM Cellular Dynamics, Inc. Microtissue formation using stem cell-derived human hepatocytes
GB201609663D0 (en) 2016-06-02 2016-07-20 Stemtek Therapeutics Sl Methods for producing cancer stem cell spheroids
WO2018162623A1 (en) * 2017-03-10 2018-09-13 Merck Patent Gmbh Infected cell cultures
CN109294971A (zh) * 2018-09-29 2019-02-01 西安交通大学 一种用于药物筛选的颈动脉分叉三维细胞培养模型及其构建方法
WO2020232436A1 (en) 2019-05-16 2020-11-19 Brown University A human in vitro cardiotoxicity model
DE102019216886A1 (de) 2019-10-31 2021-05-06 Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. Transfer zumindest eines partikels in einer flüssigkeit von einer abgabeeinheit zu einer empfangseinheit
CN111471641B (zh) * 2020-02-03 2021-11-05 东华大学 多片层单元水凝胶包被的仿生毛细血管网的3d打印制法
CN111150885A (zh) * 2020-03-05 2020-05-15 陕西佰傲干细胞再生医学有限公司 软骨微囊及其制备方法和应用
US12076437B2 (en) 2021-07-12 2024-09-03 Brown University Proangiogenic protein cocktails delivered in custom biomaterials to revascularize ischemic tissue
CN121969735A (zh) 2023-10-06 2026-05-01 银丝佛若有限公司 用于研究生物样本相互作用的装置

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006032092A1 (en) * 2004-09-24 2006-03-30 Angioblast Systems, Inc. Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof
WO2007124023A2 (en) * 2006-04-21 2007-11-01 Wake Forest University Health Sciences Ink-jet printing of tissues
WO2008051568A3 (en) * 2006-10-23 2008-07-24 Anthrogenesis Corp Methods and compositions for treatment of bone defects with placental cell populations
WO2008100497A1 (en) * 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
US20100124569A1 (en) * 2008-11-19 2010-05-20 Abbot Stewart Amnion derived adherent cells
US20100129330A1 (en) * 2002-04-03 2010-05-27 Wilkison William O Adipocytic differentiated adipose derived adult stem cells and uses thereof
WO2010060080A1 (en) * 2008-11-24 2010-05-27 Immunotrex Corporation Three dimensional tissue generation
US20110229970A1 (en) * 2010-03-05 2011-09-22 Florida State University Research Foundation Dual-chamber perfusion bioreactor for orthopedic tissue interfaces and methods of use
WO2011064669A3 (en) * 2009-11-30 2011-12-15 Pluristem Ltd. Adherent cells from placenta and use of same in disease treatment
WO2011154552A1 (en) * 2010-06-11 2011-12-15 Cellartis Ab 3-dimensional scaffolds for improved differentiation of pluripotent stem cells to hepatocytes
WO2012083023A1 (en) * 2010-12-17 2012-06-21 Anthrogenesis Corporation Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells
WO2013040078A2 (en) * 2011-09-12 2013-03-21 Organovo, Inc. Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545100B1 (fr) * 1983-04-29 1985-12-20 Inst Nat Sante Rech Med Procede d'obtention de cultures d'hepatocytes humains, les cultures obtenues et leurs applications biologiques et biochimiques
WO2003055487A1 (en) * 2002-01-04 2003-07-10 The University Of Adelaide METHOD OF CONTROLLING DAMAGE MEDIATED BY α, β- UNSATURATED ALDEHYDES
JP2004254674A (ja) * 2003-02-25 2004-09-16 Mutsumi Takagi 動物細胞の分化誘導培養方法
ES2609006T3 (es) * 2009-10-16 2017-04-18 Rutgers, The State University Of New Jersey Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100129330A1 (en) * 2002-04-03 2010-05-27 Wilkison William O Adipocytic differentiated adipose derived adult stem cells and uses thereof
WO2006032092A1 (en) * 2004-09-24 2006-03-30 Angioblast Systems, Inc. Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof
WO2007124023A2 (en) * 2006-04-21 2007-11-01 Wake Forest University Health Sciences Ink-jet printing of tissues
WO2008051568A3 (en) * 2006-10-23 2008-07-24 Anthrogenesis Corp Methods and compositions for treatment of bone defects with placental cell populations
WO2008100497A1 (en) * 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
CN102282252A (zh) * 2008-11-19 2011-12-14 人类起源公司 羊膜来源的贴壁细胞
US20100124569A1 (en) * 2008-11-19 2010-05-20 Abbot Stewart Amnion derived adherent cells
WO2010060080A1 (en) * 2008-11-24 2010-05-27 Immunotrex Corporation Three dimensional tissue generation
WO2011064669A3 (en) * 2009-11-30 2011-12-15 Pluristem Ltd. Adherent cells from placenta and use of same in disease treatment
US20110229970A1 (en) * 2010-03-05 2011-09-22 Florida State University Research Foundation Dual-chamber perfusion bioreactor for orthopedic tissue interfaces and methods of use
WO2011154552A1 (en) * 2010-06-11 2011-12-15 Cellartis Ab 3-dimensional scaffolds for improved differentiation of pluripotent stem cells to hepatocytes
CN103097517A (zh) * 2010-06-11 2013-05-08 塞拉帝思股份公司 用于提高多能干细胞分化成肝细胞的3维支架
WO2012083023A1 (en) * 2010-12-17 2012-06-21 Anthrogenesis Corporation Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells
WO2013040078A2 (en) * 2011-09-12 2013-03-21 Organovo, Inc. Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF-2 during 2D expansion and BMP-2 during 3D cultivation;Ivan Martin et al.;《Journal of cellular biochemistry》;20011231;第83卷;第121-128页 *

Also Published As

Publication number Publication date
JP6492106B2 (ja) 2019-03-27
EP3132023B1 (en) 2021-06-02
SG11201608463WA (en) 2016-11-29
AU2015248875B2 (en) 2019-04-04
WO2015158777A1 (en) 2015-10-22
CA2945548A1 (en) 2015-10-22
AU2015248875A1 (en) 2016-10-27
CA2945548C (en) 2019-11-12
GB201406716D0 (en) 2014-05-28
JP2017511146A (ja) 2017-04-20
US20230235277A1 (en) 2023-07-27
DK3132023T3 (da) 2021-08-09
EP3132023A1 (en) 2017-02-22
US20170037364A1 (en) 2017-02-09
CN106459895A (zh) 2017-02-22
AU2015248875B9 (en) 2019-05-23

Similar Documents

Publication Publication Date Title
CN106459895B (zh) 制备用于3d组织培养的细胞的方法
Mohr et al. Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models
Zuppinger 3D culture for cardiac cells
Baillie-Benson et al. Pluripotent stem cell models of early mammalian development
Heidari Khoei et al. Generating human blastoids modeling blastocyst-stage embryos and implantation
CN104703698B (zh) 细胞培养
US20180305669A1 (en) Microtissue formation using stem cell-derived human hepatocytes
JP2016518831A (ja) ブラストイド、細胞株に基づく人工胚盤胞
CN111826338A (zh) 一种快速培养肝芽类器官的方法
Ghezelayagh et al. Improved differentiation of hESC-derived pancreatic progenitors by using human fetal pancreatic mesenchymal cells in a micro‐scalable three-dimensional co-culture system
Rungarunlert et al. Slow turning lateral vessel bioreactor improves embryoid body formation and cardiogenic differentiation of mouse embryonic stem cells
KR20250156756A (ko) 배아 착상의 진단 및 최적화를 위한 줄기세포 및 오르가노이드 기반 방법
Kim et al. Prediction of Acute Hepatotoxicity With Human Pluripotent Stem Cell‐Derived Hepatic Organoids
Fuegemann et al. Differentiation of mouse embryonic stem cells into cardiomyocytes via the hanging‐drop and mass culture methods
CN105695392B (zh) 一种可提高肝细胞体外分化表型及功能的培养方法
US20070148767A1 (en) Method of forming multicellular spheroids from the cultured cells
JPWO2011016485A1 (ja) ｉＰＳ細胞から肝実質細胞への分化誘導方法
Tao et al. Enhancement and maintenance of hepatic metabolic functions by controlling 3D aggregation of cryopreserved human iPS cell-derived hepatocyte-like cells
JP5758061B2 (ja) 細胞クラスターの生成法
JP2022521238A (ja) 羊水細胞由来のｅｃｍ上での心筋細胞の成熟化のための方法、細胞構築物、ならびに薬物化合物の心毒性および催不整脈スクリーニングのための使用
CN120187844A (zh) 体外培养胚胎的三维共培养系统及其应用
US20230392123A1 (en) Spheroidal self-assembled peptide hydrogels comprising cells
JP6486619B2 (ja) 薬物評価用細胞及び薬物評価方法
Raggi et al. Generation of complex syngeneic liver organoids from induced pluripotent stem cells to model human liver pathophysiology
TW201734206A (zh) 高機能肝細胞及其利用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant